Moleculin Biotech - 48 Year Dividend History | MBRX

Historical dividend payout and yield for Moleculin Biotech (MBRX) since 1971. The current TTM dividend payout for Moleculin Biotech (MBRX) as of August 22, 2019 is $0.00. The current dividend yield for Moleculin Biotech as of August 22, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.052B $0.000B
Moleculin Biotech, Inc. is a preclinical and clinical-stage pharmaceutical company which focused on the development of anti-cancer drug candidates. The company's lead product candidate is Annamycin, a Phase II clinical stage anthracycline for the treatment of relapsed or refractory acute myeloid leukemia. Moleculin Biotech, Inc. is based in Houston, TX.
Stock Name Country Market Cap PE Ratio